Keynote Speakers
Annette S. Kim, MD, PhD
Annette S. Kim, MD, PhD is the Henry Clay Bryant Professor and Division Head of Diagnostic Genetics and Genomics at the University of Michigan. Dr. Kim’s research program has focused on the study of hematolymphoid malignancies, including miRNAs in myelodysplastic syndromes, myeloid and lymphoid mutational patterns, and test utilization management.
She has served as a member of Molecular Oncology Committee and is currently Chair of the Personalized Healthcare Committee for College of American Pathologists. She is also Program Chair of the Association for Molecular Pathology and Past-Chair of the ASH Subcommittee on Precision Medicine. In 2019, Dr. Kim was awarded the CAP Public Service Award and in 2025 she received the CAP Laboratory Improvement Programs Service Award.
Guillermina (Gigi) Lozano, PhD
Dr. Guillermina (Gigi) Lozano received her BS degree in Biology and Mathematics, Magna Cum Laude, from Pan American University and her PhD from Rutgers University and the University of Medicine and Dentistry of New Jersey. She performed post-doctoral studies with Dr. Arnold Levine at Princeton University.
Dr. Lozano is currently professor and chair of the Department of Genetics at The University of Texas MD Anderson Cancer Center and holds the Hubert L. Olive Stringer Distinguished Chair in Oncology in Honor of Sue Gribble Stringer. She is internationally recognized as one of the world’s foremost cancer researchers for her trailblazing work to uncover mechanisms of p53 tumor suppression. She was the first to identify p53 as a transcriptional activator, and she highlights its mutation or deletion as a hallmark of many cancers. She also identified the physiological roles of Mdm2 and Mdm4 as gatekeepers in regulating p53 activity. Among numerous honors, Lozano is a member of the National Academy of Medicine, the National Academy of Sciences and the American Academy of Arts and Sciences.
Philip Lupo, PhD, MPH
Dr. Philip Lupo is a genetic epidemiologist, a Professor of Pediatrics at Emory University, and Co-Director of the REACH Center at Emory University and Children’s Healthcare of Atlanta. Dr. Lupo’s research focuses on cancer predisposition in children and outcomes in these individuals.
This work is facilitated through his work in the Children’s Oncology Group, where he is the Chair of the Epidemiology Committee. Examples of his currently funded research include the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Study, an international collaboration to identify novel cancer predisposition syndromes in children with structural birth defects; the Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Study; and the Genetic Information for Families after Tumor Testing (GIFTT) Study, which seeks to evaluate outcomes in children with cancer predisposition syndromes and increase uptake of genetic services in their family members. The goal of Dr. Lupo/s research is to discover factors that can be used in new prevention efforts and targeted interventions to limit the adverse consequences of pediatric cancer.